A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2004
12/29/2004	WO2004113300A1 Novel tricyclic heterocycle compound
12/29/2004	WO2004112824A1 Hip/pap polypeptide composition for use in liver regeneration and for the prevention of liver failure
12/29/2004	WO2004112756A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
12/29/2004	WO2004112505A1 Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things
12/29/2004	WO2004089964A8 Lipid-regulating agent and use thereof
12/29/2004	WO2004048419A9 Method of classifying, purifying and using fenugreek seeds
12/29/2004	WO2004024237A3 Methods for sterilization using in situ gelling materials
12/29/2004	WO2004002940A8 Inhibitors of hcv ns5b polymerase
12/29/2004	WO2003103671A8 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/29/2004	WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
12/29/2004	WO2002043648A3 Compounds active at the glucocorticoid receptor ii
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004	EP1491543A1 Intermediate compounds
12/29/2004	EP1491542A2 Intermediate compounds
12/29/2004	EP1491539A1 1-n-aminobenzimidazole derivatives
12/29/2004	EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491215A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
12/29/2004	EP1491214A1 Drugs for treating liver diseases with the use of hollow protein nanoparticles
12/29/2004	EP1491204A1 Process for producing fat composition containing hydrophobic components of glycyrrhiza
12/29/2004	EP1491194A1 Vdac regulator
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
12/29/2004	EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004	EP1490480A2 Primitive and proximal hepatic stem cells
12/29/2004	EP1490406A1 Costimulatory molecule and its use
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490367A1 Imidazopyridine derivatives as kinase inhibitors
12/29/2004	EP1490366A1 Novel alkoxypyridine-derivatives
12/29/2004	EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases
12/29/2004	EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/29/2004	EP1490358A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
12/29/2004	EP1490357A1 Stable hydrate of a muscarinic receptor antagonist
12/29/2004	EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
12/29/2004	EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490341A1 Novel adamantane derivatives
12/29/2004	EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
12/29/2004	EP1490339A1 Novel chalcone derivatives and uses thereof
12/29/2004	EP1490335A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490119A1 Tissue treatment
12/29/2004	EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004	EP1490081A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/29/2004	EP1490079A1 A composition for treating gastric ulcer and a process for preparing the same
12/29/2004	EP1490078A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450
12/29/2004	EP1490072A1 Novel therapeutical use of agonist ligands specific to g2a receptor
12/29/2004	EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490063A1 Use of proton pump inhibitors for the treatment of noncardiac chest pain
12/29/2004	EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490055A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
12/29/2004	EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/29/2004	EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
12/29/2004	EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004	EP1490033A1 No-donating nsaids adsorbed into carrier particles
12/29/2004	EP1490025A2 Nanoparticulate compositions of map kinase inhibitors
12/29/2004	EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
12/29/2004	EP1489915A1 Treatment and prevention of inflammatory disorders
12/29/2004	EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004	EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/29/2004	EP1204646B1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor
12/29/2004	EP1196180B1 Treatment of angiogenesis dependent conditions with dextrin sulphate
12/29/2004	EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1123274B1 Substituted phenyl derivatives, their preparation and use
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558946A New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/29/2004	CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/29/2004	CN1558903A Water-soluble phenylpyridazine compounds and compositions containing the same
12/29/2004	CN1558894A Method for the nitration of phenolic compounds
12/29/2004	CN1558776A Solid composition containing bacillus-type non-pathogenic bacterial spores
12/29/2004	CN1558771A Method for treating hepatitis c virus infection in treatment failure patients
12/29/2004	CN1558768A A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558763A Treatment of hepatitis B virus infection with human monoclonal antibodies
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1558754A Pharmaceutical dosage form with multiple coatings
12/29/2004	CN1558752A Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease
12/29/2004	CN1557833A Eplerenone crystalline form exhibiting enhanced dissolution rate
12/29/2004	CN1557494A Preparation of microorganism resisting biological active component and its application
12/29/2004	CN1557493A Specific antibody for preventing and treating periodontal disease
12/29/2004	CN1557492A Helicobacter Pylori resisting specific immune globulin preparation
12/29/2004	CN1557491A Specific antibody preparation for inhibiting decayed tooth bacteria
12/29/2004	CN1557489A Preparation of oral administered immune globulin from whey
12/29/2004	CN1557470A Natural nutrient for preventing and treating multiple oral disease
12/29/2004	CN1557463A Ganoderma lucidum and gynostemma pentaphylla oral liquid
12/29/2004	CN1557462A Medicinal composition for treating chronic and prolonged hepatitis
12/29/2004	CN1557459A Euterma Wasabi contained medicine or health product
12/29/2004	CN1557439A Medicinal capsule of cactus for treating gastric disease and its preparation
12/29/2004	CN1557437A Mixture of aucklandia root and garden burnet for easing stomach and its preparation
12/29/2004	CN1557436A Granular medicine of siberian solomoseal rhizome and andastragalus root and its preparing process
12/29/2004	CN1557433A Chinese medicine for treating gastric disease

1 ... 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 ... 1258